| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| TEVA, TEVJF | TEVA PHARMACEUTICAL INDUSTRIES LTD | Executive Vice President, Global R&D and Chief Medical Officer | $0 | -$1.31M | -100% | Aug 9, 2024 |
| GLUE | Monte Rosa Therapeutics, Inc. | Director | Dec 11, 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|